weight loss drug

weight loss drug

Bags of chips and other snack foods are displayed on shelves at a store in Hamilton, Ontario, Canada, January 28, 2025. Photo: REUTERS/Carlos Osorio

Weight-loss pill approval set to accelerate food industry product overhauls

More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. Photo: REUTERS/Tom Little

What Novo Nordisk's weight-loss pill approval means for company, patients

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

Novo Nordisk wins US approval for weight-loss pill

A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Photo: REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo

As weight-loss spending soars, US employers plan to pare health benefits

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

How Novo Nordisk misread the US market for its weight loss sensation

Headquarter of  Novo Nordisk, a leading global healthcare company operating in the Human insulin market. Photo: Collected

Weight-loss drug forecasts jump to $150 billion as supply grows